137 related articles for article (PubMed ID: 36912267)
1. DNA methylation testing for endometrial cancer detection in urine, cervicovaginal self-samples and cervical scrapes.
Wever BMM; van den Helder R; van Splunter AP; van Gent MDJM; Kasius JC; Trum JW; Verhoeve HR; van Baal WM; Hulbert A; Verhoef L; Heideman DAM; Lissenberg-Witte BI; van Trommel NE; Steenbergen RDM; Bleeker MCG
Int J Cancer; 2023 Jul; 153(2):341-351. PubMed ID: 36912267
[TBL] [Abstract][Full Text] [Related]
2. HPV and DNA Methylation Testing in Urine for Cervical Intraepithelial Neoplasia and Cervical Cancer Detection.
van den Helder R; Steenbergen RDM; van Splunter AP; Mom CH; Tjiong MY; Martin I; Rosier-van Dunné FMF; van der Avoort IAM; Bleeker MCG; van Trommel NE
Clin Cancer Res; 2022 May; 28(10):2061-2068. PubMed ID: 35266975
[TBL] [Abstract][Full Text] [Related]
3. Cervical cancer detection by DNA methylation analysis in urine.
Snoek BC; Splunter APV; Bleeker MCG; Ruiten MCV; Heideman DAM; Rurup WF; Verlaat W; Schotman H; Gent MV; Trommel NEV; Steenbergen RDM
Sci Rep; 2019 Feb; 9(1):3088. PubMed ID: 30816167
[TBL] [Abstract][Full Text] [Related]
4. CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer.
De Strooper LM; van Zummeren M; Steenbergen RD; Bleeker MC; Hesselink AT; Wisman GB; Snijders PJ; Heideman DA; Meijer CJ
J Clin Pathol; 2014 Dec; 67(12):1067-71. PubMed ID: 25281766
[TBL] [Abstract][Full Text] [Related]
5. Complementarity between miRNA expression analysis and DNA methylation analysis in hrHPV-positive cervical scrapes for the detection of cervical disease.
Babion I; De Strooper LMA; Luttmer R; Bleeker MCG; Meijer CJLM; Heideman DAM; Wilting SM; Steenbergen RDM
Epigenetics; 2019 Jun; 14(6):558-567. PubMed ID: 30955437
[TBL] [Abstract][Full Text] [Related]
6. Endometrial Cancer Detection by DNA Methylation Analysis in Cervical Papanicolaou Brush Samples.
Wang SF; Du CY; Li M; Wen B; Shen QJ; Ma F; Zhang L; Deng H
Technol Cancer Res Treat; 2024; 23():15330338241242637. PubMed ID: 38584417
[No Abstract] [Full Text] [Related]
7. Non-invasive detection of endometrial cancer by DNA methylation analysis in urine.
van den Helder R; Wever BMM; van Trommel NE; van Splunter AP; Mom CH; Kasius JC; Bleeker MCG; Steenbergen RDM
Clin Epigenetics; 2020 Nov; 12(1):165. PubMed ID: 33143739
[TBL] [Abstract][Full Text] [Related]
8. Methylation analysis in urine fractions for optimal CIN3 and cervical cancer detection.
van den Helder R; van Trommel NE; van Splunter AP; Lissenberg-Witte BI; Bleeker MCG; Steenbergen RDM
Papillomavirus Res; 2020 Jun; 9():100193. PubMed ID: 32171935
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens.
Gupta A; Arora R; Gupta S; Prusty BK; Kailash U; Batra S; Das BC
J Clin Virol; 2006 Nov; 37(3):190-4. PubMed ID: 16931139
[TBL] [Abstract][Full Text] [Related]
10. Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape.
Snellenberg S; De Strooper LM; Hesselink AT; Meijer CJ; Snijders PJ; Heideman DA; Steenbergen RD
BMC Cancer; 2012 Nov; 12():551. PubMed ID: 23176198
[TBL] [Abstract][Full Text] [Related]
11. Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy.
Hesselink AT; Heideman DA; Steenbergen RD; Gök M; van Kemenade FJ; Wilting SM; Berkhof J; Meijer CJ; Snijders PJ
Int J Cancer; 2014 Aug; 135(4):880-6. PubMed ID: 24474183
[TBL] [Abstract][Full Text] [Related]
12. A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer: Validation in Several Cohort and Case/Control Sets.
Herzog C; Marín F; Jones A; Evans I; Reisel D; Redl E; Schreiberhuber L; Paytubi S; Pelegrina B; Carmona Á; Peremiquel-Trillas P; Frias-Gomez J; Pineda M; Brunet J; Ponce J; Matias-Guiu X; de Sanjosé S; Alemany L; Olaitan A; Wong M; Jurkovic D; Crosbie EJ; Rosenthal AN; Bjørge L; Zikan M; Dostalek L; Cibula D; Sundström K; Dillner J; Costas L; Widschwendter M
J Clin Oncol; 2022 Nov; 40(33):3828-3838. PubMed ID: 36001862
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation analysis in liquid-based cytology for cervical cancer screening.
Apostolidou S; Hadwin R; Burnell M; Jones A; Baff D; Pyndiah N; Mould T; Jacobs IJ; Beddows S; Kocjan G; Widschwendter M
Int J Cancer; 2009 Dec; 125(12):2995-3002. PubMed ID: 19609949
[TBL] [Abstract][Full Text] [Related]
14. FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women.
Luttmer R; De Strooper LM; Dijkstra MG; Berkhof J; Snijders PJ; Steenbergen RD; van Kemenade FJ; Rozendaal L; Helmerhorst TJ; Verheijen RH; Ter Harmsel WA; van Baal WM; Graziosi PG; Quint WG; Spruijt JW; van Dijken DK; Heideman DA; Meijer CJ
Br J Cancer; 2016 Aug; 115(5):579-87. PubMed ID: 27415009
[TBL] [Abstract][Full Text] [Related]
15. The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings.
Chang CC; Wang HC; Liao YP; Chen YC; Weng YC; Yu MH; Lai HC
J Gynecol Oncol; 2018 Jan; 29(1):e17. PubMed ID: 29185275
[TBL] [Abstract][Full Text] [Related]
16. Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study).
Luttmer R; De Strooper LM; Berkhof J; Snijders PJ; Dijkstra MG; Uijterwaal MH; Steenbergen RD; van Kemenade FJ; Rozendaal L; Helmerhorst TJ; Verheijen RH; Ter Harmsel WA; Van Baal WM; Graziosi PG; Quint WG; Heideman DA; Meijer CJ
Int J Cancer; 2016 Feb; 138(4):992-1002. PubMed ID: 26317579
[TBL] [Abstract][Full Text] [Related]
17. Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1/MAL methylation analysis on cervical scrapes.
Verhoef VM; van Kemenade FJ; Rozendaal L; Heideman DA; Bosgraaf RP; Hesselink AT; Melchers WJ; Massuger LF; Bekkers RL; Steenbergen RD; Berkhof J; Snijders PJ; Meijer CJ
Gynecol Oncol; 2015 Apr; 137(1):55-9. PubMed ID: 25667975
[TBL] [Abstract][Full Text] [Related]
18. Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway-PaVDaG study).
Stanczuk G; Baxter G; Currie H; Lawrence J; Cuschieri K; Wilson A; Arbyn M
BMJ Open; 2016 Apr; 6(4):e010660. PubMed ID: 27113237
[TBL] [Abstract][Full Text] [Related]
19. Performance and Diagnostic Accuracy of Human Papillomavirus Testing on Self-Collected Urine and Vaginal Samples in a Referral Population.
Cho HW; Hong JH; Min KJ; Ouh YT; Seong SJ; Moon JH; Cho SH; Lee JK
Cancer Res Treat; 2021 Jul; 53(3):829-836. PubMed ID: 33421987
[TBL] [Abstract][Full Text] [Related]
20. CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease.
Bierkens M; Hesselink AT; Meijer CJ; Heideman DA; Wisman GB; van der Zee AG; Snijders PJ; Steenbergen RD
Int J Cancer; 2013 Sep; 133(6):1293-9. PubMed ID: 23456988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
